Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
You know, the human brain can think more than once thing at once. I'm buying, and will keep buying all the way to a pound. Possibly more if news flow is good. Couple of points though. Raises with big dillutions are bad, it kind of universally accepted they are bad. They are bad for long term shareholders, they make the company look weak, inductions, will avoid and so on. If the board had pulled their finger out and secured a deal. You could've still bought cheap shares that didn't dillute everyone else's right up to the point where the deal was announced. I think it's just plain weird, why you can't bring yourself to say it. Yes we may all end up with what we wanted but we all had to risk more cash to do it. Unchallenged and you end up with VAL or any of the dozens of other companies that with good intentions or not, ended up shafting their loyal shareholders.
Truer words have never been spoken Lazarus.
An opportunity I have seen a few times in Sareums history, would not have missed it for the world.
Gla
100% agree Lazarus2.
I now have 55,000 more shares and my sp ave. has dropped from £2.58 to 96p!
I'm ecstatic, but not as ecstatic as I'll be with a T/O offer north of £1bn! (When/if that arrives?)
I believe it is over 11 months, Carter.
Aren’t you all overlooking the fact that you all probably have many more Sareum shares in your portfolio as a direct consequence of this dilution? Ample compensation I would say. At least be balanced
A fair analogy Oracle, not sure how many mths have passed now since the start of the trials and no bad news as yet.
Yes, all calculations need to be gone on market cap. I know that's you should go it but we all throw sp predictions around that need to be recalculated. I still think that if all goes well, SAR could have a valuations of around 2 billion. End of phase 2 going into phase 3. Before RF that wasn't far off £30 per share. We'd now need a 3 billion valuation to get the same £30. Generally, I dont have a issue with raises and dillution but it's the scale of this one that grates on me. The cash from RF, the Raise and the wrap genrated less than £5 million pounds but cost approx 40 million shares. If the SP were to get back to £1 that's a £40 million cost to run a phase 1 trials, if it got to £10. That a £400 million cost. Worse than than that. The whole saga hasn't even secured our financial future. If the RF facility was the best option, what was the worst?
I will forgive Tim minutely regarding this post consolidation funding debacle for one tiny reason. The MHRA fiasco.
They've moved with haste as we all know and Krones earlier post highlights again. Yes they should have placed earlier and simply could have called on shareholders ONLY. But many slimy and rotten hands may or may not be after Sareum.
These upcoming results we would have had months ago and I can't imagine where we'd be today.
Onwards and upwards.
Just seen my dire team surrender a 3 goal lead to Coventry .. SAR at £2 would frankly be “less” of a surprise!!
Hoping to see an RNS this week confirming MAD is complete, must be due and then in my mind the real fun begins as the data allows us to progress with broader options. I still think that a deal from the 1a data is a highly probable outcome. GLA
Unfortunately share dilution generally comes with the territory, here’s hoping for good data.
Just to quantify my understanding of the share dilution since December 2000 when there were 64 million shares (post consolidation calculation; there were actually just over 3,200 million shares so / by 50). There are now 104 million shares so the dilution is 38.5% approximately. So if SAR did reach a market cap of £1 billion the share price now with 104 million shares would be £9.60 compared with a price of £15.60 before all the dilutions.
Appreciated Damion.
I’m sure you’ll do well from it.
I’ve banked 6 figures from this previously, it paid for our extension and the other half’s Porker.
I’m hoping for some movement before another share I have my eye on picks up. Hopefully bounce some profits from here to there and then that’s my Ferrari F8 paid for.
£1 a share could quite easily be seen this quarter. Only 2p in old money, albeit we’ve had a bit of dilution.
How incredibly undeserved 🙄
RF Sell of which they made just shy of £300k profit on 1.95m shares /
Did anyone confirm if the above was a buy ?
Great find. Thanks.
Nice find Krone.
Https://pharmasols.com/resources-insights/case-studies/rapid-study-start-up-for-phase-1-dermatology-study-in-australia-for-a-uk-biotech-company/
Pharmaceutical Solutions Australia Pty Ltd noted on the ANZCTR website as the primary sponsor. https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=385555&isReview=true
To think RF will probably be selling the last lot and then buying their warrants to sell at a healthy 150%, or more, if they hold off.
Maybe they will need their cash to facilitate their reverse TO, then go bust and not buy the warrants.
Thanks for the info SOG. Was more a playful dig!
I’m just a small investor but desperate for SAR to hit those dizzy heights.
Those 1700 shares cost me £5.4k back in the day and due to downward death spiral and work needed on the house I sold out at Xmas for £1200. Luckily I managed to purchase 3300 at 0.10.6 as I checked to see how SAR were doing on the off chance! Then a further 1700 at 0.20 ish. I’ve since recovered my initial investment safely and have 3550 riding along well in profit.
Happy days, personally I think 30p will be passed and out of sight next week.
Well spotted Prince mincer,
In the 20's stll, as news not only of a further drawdown of 3,000,000 shares but the vast number of these forward sold into the market today.
How many of your 1,700 shares do you have left?
Did you take advantage of the WRAP offer?
Have you added or sold any?
Clearly, you are very easily disappointed. I take you have no disappointment with RF?
New week starts Monday, RF doing their utmost to destroy the SP but will be gone very soon.
220k still to pay around 2.2 million shares.
Price will climb steadily with Riverfort out of the equation.
I am not disappointed as bought another 10k.
To be fair it was a tough call which way the SP was going after the last week's increases, good to see RF nearly cleared now that news is most likely priced in as markets know it's coming before the end of the month. Trial end Mad premilinary should add support then its all eyes on the Full P1a now end of Q2 GLA
Zzzzz and sleep Prince.